Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.642, 2011-01, pp. : 12-12
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 644, 2012-01 ,pp. :
Access to resources
Recommend
NICE recommends nilotinib and golimumab . . .
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 636, 2011-01 ,pp. :
NICE recommends rituximab for follicular lymphoma . . .
Inpharma, Vol. 1, Iss. 1559, 2006-01 ,pp. :
NICE recommends dexamethasone intravitreal implant, . . .
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 631, 2011-01 ,pp. :
NICE no longer recommends omalizumab for asthma . . .
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 667, 2012-01 ,pp. :